Breaking the mould: New technology sectors in an old industrial region

International Journal of Biotechnology

Volumn 5, Issue 3-4, 2003, Pages 249-268

  Benneworth, Paul ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biotechnology; Innovation; Institutional support; Regional development; Technological evolution

Indexed keywords

DRUG PRODUCTS PLANTS; RESEARCH AND DEVELOPMENT MANAGEMENT;

COMMERCIALIZATION; INFRASTRUCTURE;

BIOTECHNOLOGY;

BIOTECHNOLOGY; INNOVATION; REGIONAL DEVELOPMENT; RESEARCH AND DEVELOPMENT; SCIENCE AND TECHNOLOGY;

AGRICULTURE; COMMERCIAL PHENOMENA; DRUG INDUSTRY; EMPLOYMENT; FOOD ANALYSIS; FOOD BIOTECHNOLOGY; FOOD INDUSTRY; GEOGRAPHIC DISTRIBUTION; HUMAN; MARKETING; POLICY; REVIEW; SCIENCE;

EID: 1842429610     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/ijbt.2003.004097     Document Type: Review

References (54)

1. Orsenigo, L. (2001) 'The (failed) development of a biotechnology cluster: the case of Lombardy' Small Business Economics, Vol. 17, Nos. 1/2, pp.77-92.
2. Taggart, J. (1993) The World Pharmaceutical Industry, Routledge, London.
3. The Motley Fool investment website [4] reported Lehman Brothers research stating that in 2003 GSK face five approvals worth $4 billion in annual sales (13% of 2001 sales), and Eli Lilly have four approvals worth $5.5 billion in annual sales (47% of 2001 sales).
4. The Motley Fool (2003) 'AOL under the Knife', The Motley Fool, 10 January. Available from: www.fool.company/news/take/2003/take0301010.htm [Accessed 13 January 2003].
5. Walcott, S.M. (1998) 'The Indianapolis 'Fortune 500': Lilly and regional renaissance', Environment and Planning A, Vol. 30, No.10, pp.1723-1741.
6. Powell, W.W., Koput, K.W. and Smith-Doerr, L. (1996) 'Inter-organisational collaboration and the locus of innovation: networks of learning in biotechnology,' Administrative Science Quarterly, Vol. 41, No.1, pp.116-145.
7. Cooke, P.N. (2001) 'Biotechnology clusters in the UK: lessons from localisation in the commercialisation of science', Small Business Economics, Vol. 17, No.1, pp.43-59.
8. The Economist (1998) 'The Alchemists', Survey: the Pharmaceutical Industry, 21 February, pp.3-4.
9. Lord Sainsbury (1999) Biotechnology Clusters: the Sainsbury report, London, DTI.
10. Cooke, P.N. (1995) The Rise of the Rustbelt, ICL Press, London.
11. Nilsson, A. (2001) 'Biotechnology firms in Sweden', Small Business Economics, Vol. 17, Nos. 1/2, pp.93-104.
12. Howells, J. and Wood, M. (1993) The Globalisation of Production and Technology, Belhaven, London.
13. Padmore, T., Schütze, H. and Gibson, H. (1998) 'Modelling systems of innovation: an enterprise-centred view', Research Policy, Vol. 26, pp.605-624.
14. Cawson, A., Haddon, L. and Miles, I. (1995) The Shape of Things to Consume: Delivering Information Technology into the Home, Avebury, Aldershot.
15. Amin, A. and Palan, R. (2001) 'Towards a non-rationalist international political economy', Review of International Political Economy, Vol. 8, No.4, pp.559-577.
16. The Economist (1997) 'World in figures: pharmaceuticals', The World in 1998, pp.97.
17. Oakey, P., Faulkner, W., Cooper, S. and Walsh, V. (1990) New Firms in the Biotechnology Industry: Their Contribution to Innovation and Growth, Pinter, London.
18. Russell, S. and Williams, R. (2002) 'Concepts, spaces and tools for action? Exploring the policy potential of the social shaping perspective', in K.H. Sørensen and R. Williams (Eds.) Shaping Technology, Guiding Policy: Concepts, Spaces and Tools, Edward Elgar, Cheltenham.
19. Fontes, M. and Coombs, R. (2001) 'Contribution of new technology based firms to the strengthening of technological capabilities in intermediate economies', Research Policy, Vol. 30, pp.79-97.
20. Etkowitz, H. and Leydesdorff, L. (1997) Universities and the Global Knowledge Economy, Pinter, London.
21. Although, as 1 later argue, there is increasing recognition that pharmaceutical-driven innovation is only the highest profile element of the various forms of biotechnology innovation.
22. Lundvall, B.A. (1988) 'Innovation as an interactive process: from user-producer interaction to the national system of innovation', in G. Dosi (Ed.) Technical Change and Economic Theory, Pinter, London.
23. Freeman, C. (1995) 'The national system of innovation in a historic perspective', Cambridge Journal of Economics. Vol. 18, No.1, pp.5-24.
24. Giesecke, S. (2000) 'The contrasting roles of government in the development of biotechnology industry in the USA and Germany', Research Policy, Vol. 29, No.2, pp.205-223.
25. Cooke, P.N. (2002) 'Regional innovation systems: general findings and some new evidence from biotechnology clusters', Journal of Technology Transfer, Vol. 27, pp.133-145.
26. Markusen, A.R. (1994) 'Studying regions by studying firms,' Professional Geographer, Vol. 46, No.4, pp.477-490,
27. Martin, S. and Scott, J.T. (2000) 'The nature of innovation markets failure and the design of public support for private innovation', Research Policy, Vol. 29, pp.437-447.
28. Hudson, R. (1995) 'The role of foreign inward investment', in L. Evans, P. Johnson and B. Thomas (Eds.) The Northern Regional Economy.' Progress and Prospects in the North of England, Mansell, London.
29. North of England Development Council (1984) Biotechnology in the North of England, NEDC, Newcastle.
30. An alternative analysis is available in [31].
31. Benneworth, P.S. (2002) 'Innovation and modernisation in a peripheral industrial region: the case of the North East of England', Unpublished PhD Thesis, University of Newcastle upon Tyne, UK.
32. inter alia; Brown, G. (1997) The Potential State of the Pharmaceutical Sector in the Northern Region, Newcastle, Northern Development Company.
33. Cf. NEDC [29] and Brown [32] for examples of very limited local biotechnology databases available before 2001.
34. Yin, R. (1994) Case Study Research: Design and Methods, Sage Publications, Thousand Oaks.
35. Angle Technology (2001) North East Bioscience Cluster Mapping, ONE, Newcastle upon Tyne.
36. Pike, A. (1998) 'Making performance plants from branch plants? In situ restructuring in the automobile industry in the UK,' Environment & Planning A, Vol. 30, pp.881-900.
37. Maskell, P. and Malmberg, P. (1999) 'Localised learning and industrial competitiveness', Cambridge Journal of Economics, Vol. 23, No.1, pp.167-185.
38. Williams, H. and Charles, D.R. (1986) 'Electronics in the North East of England: growth or decline,' Northern Economic Review, Vol. 13, pp.29-38
39. Charles, D.R. and Benneworth, P.S. (1999) 'Plant closure and institutional modernisation: Siemens semi-conductors in the North East', Local Economy, Vol. 14, No.3, pp.200-213.
40. The three firms, Avecia, Dobfar and Chirex are included in the pharmaceutical sector from the perspective of this paper, and so their employment has been omitted from Table 4 in seeking to gauge the size of the industry in the North East.
41. Fuchs, G. and Wolf, H.G. (1997) 'Regional economies, interactive television and inter-organisational networks - a case study of an innovation network in Baden-Württemberg', Paper presented to 2nd International Conference on Industry. Innovation and Territory, University of Lisbon, Portugal, 20-22 March 1997.
42. Dubini, P. (1989) 'The influence of motivations and environment on business start-ups: some hints for public policy', Journal of Business Venturing, Vol. 4, No.1, pp.11-26.
43. Fontes, M. and Coombs, R. (2001) 'Contribution of new technology based firms to the strengthening of technological capabilities in intermediate economies', Research Policy, Vol. 30, pp.79-97.
44. Porter, M.E. (1998) On Competition, Harvard Business School, Boston.
45. Benneworth, P.S. (2001) 'Long-term academic relationships and high-technology small firms', Enterprise and Innovation Management Studies, Vol. 2, No.2, pp.225-238.
46. In the period since the fieldwork was undertaken, firms have continued to form at a relatively steady rate (2-3 per year); the most interesting example is a spin-off from one of the pharmaceutical plants in which the entrepreneurs used their credibility in the sector gained at the parent to raise significant sums of venture capital to establish a firm which was involved in molecular chemical engineering (far more an engineering than science innovation).
47. Muller, E. and Zenker, A. (2001) 'Business services as actors of knowledge transformation: the role of KIBS in regional and national innovation systems', Research Policy, Vol. 30, No.9, pp.1501-1516.
48. The idea of densification is taken from Fontes and Coombs [43].
49. Cooke, P.N. (2002) 'Biotechnology clusters as regional, sectoral innovation systems', International Regional Science Review.
50. Wicksteed, B. (2000) The Cambridge Phenomenon Revisited, Segal Quince Wicksteed, Cambridge, UK.
51. Bathelt, H. (2001) 'Regional competence and economic recovery: divergent growth paths in Boston's high technology economy', Entrepreneurship and Regional Development, Vol. 13, pp.287-314.
52. Nightingale, P. (1998) 'A cognitive model of innovation', Research Policy, Vol. 27, pp.689-709.
53. Wood, P. (2002) 'Innovation and the growth of business consultancy: parallel but associated trends' in P. Wood (Ed.) Consultancy and Innovation: the Business Service Revolution in Europe, Routledge, London.
54. East of England Development Agency (1999) Moving Forward: a Strategy for the East of England, EEDA, Cambridge.